Use of botulinum toxin type A in management of adult spasticity--a European consensus statement

J Rehabil Med. 2003 Mar;35(2):98-9. doi: 10.1080/16501970306112.

Authors

Anthony B Ward¹, Miguel Aguilar, Zegers De Beyl, Susanne Gedin, Petr Kanovsky, Franco Molteni, Jörg Wissel, Anton Yakovleff

Affiliation

¹ Department of Rehabilitation Medicine, North Staffordshire Hospital, Stoke-on Trent, UK.

PMID: 12691340
DOI: 10.1080/16501970306112

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Botulinum Toxins, Type A / adverse effects
Botulinum Toxins, Type A / therapeutic use*
Consensus
Dose-Response Relationship, Drug
Drug Administration Schedule
Europe
Female
Humans
Injections, Intramuscular
Male
Muscle Spasticity / diagnosis
Muscle Spasticity / drug therapy*
Muscle Spasticity / rehabilitation
Risk Assessment
Severity of Illness Index
Treatment Outcome

Substances

Botulinum Toxins, Type A